US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ADTX

Aditxt (ADTX)

Aditxt Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/05/21	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ADTX	Aditxt Inc
2024/05/15	19 : 50	PR Newswire (US)	Evofem Biosciences Announces Financial Results for the First Quarter of 2024	NASDAQ:ADTX	Aditxt Inc
2024/05/14	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/05/09	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/05/08	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/05/04	03 : 14	Business Wire	CORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules	NASDAQ:ADTX	Aditxt Inc
2024/05/03	22 : 00	Business Wire	Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules	NASDAQ:ADTX	Aditxt Inc
2024/04/02	21 : 30	Business Wire	Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)	NASDAQ:ADTX	Aditxt Inc
2024/03/27	21 : 36	PR Newswire (US)	Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023	NASDAQ:ADTX	Aditxt Inc
2024/03/12	05 : 51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/03/07	21 : 54	PR Newswire (US)	For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy	NASDAQ:ADTX	Aditxt Inc
2024/03/05	07 : 27	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ADTX	Aditxt Inc
2024/03/05	07 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/03/02	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/03/01	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/23	07 : 21	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ADTX	Aditxt Inc
2024/02/22	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/17	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/16	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/14	23 : 26	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ADTX	Aditxt Inc
2024/02/10	06 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/07	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/03	06 : 28	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:ADTX	Aditxt Inc
2024/02/03	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/02/01	22 : 00	PR Newswire (US)	Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023	NASDAQ:ADTX	Aditxt Inc
2024/01/31	07 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/01/31	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ADTX	Aditxt Inc
2024/01/30	22 : 30	Business Wire	Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications	NASDAQ:ADTX	Aditxt Inc
2024/01/24	06 : 18	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ADTX	Aditxt Inc

Showing the most relevant articles for your search:NASDAQ:ADTX

1 2 3 4 5 6 7 8 9 10 次へ >>

Atlantic Petroleum P/f

Redcastle Resources

Accsys Technologies

Jeronimo Martins SGPS

Arista Networks

iShares MSCI Brazil ETF

Sunoco Logistics Partners L.P.

SPEAR Investments

Registry Direct

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約